CD4 and neoplasm: In this regard, statistical comparison between the no tumor, low and high tumor burden group revealed significant differences for CD69+ CD4+ lymphocytes in spleens and for both CD25+ CD8+ and CD69+/CD25+ CD4+ lymphocytes in ndLN (all p < 0.05; Kruskal–Wallis test).